Developer of a device that prevents Ventilator Associated
Pneumonia in ICU patients, by clearing airway secretions
non-invasively and more effectively than the current gold
standard: invasive catheter suction.
Employees: 4
Main Markets:
Respiratory care facilities, Patients with Neuromuscular diseases.
Overview
INNOVENT MEDICAL SOLUTIONS LTD. is a development stage company
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
that was founded in 2003 to commercialize a new airway clearance
technology first invented at Alyn Rehabilitation Hospital for use
with its respiratory patients. The device, a patented combination
of a suction unit and a disposable valve, offers a revolutionary
approach to preventing a major healthcare problem in the ICU:
Ventilator Associated Pneumonia (VAP).
The INNOVENT system is comprised of a specialized suction device,
and a disposable valve that links the suction device to the
patient's ventilator. The suction device and valve work in
synchrony with the ventilator to clear secretions non-invasively
by simulating a natural cough. The INNOVENT system promises to
clear airway secretions more effectively than catheter suction,
to enable patients to avoid endotracheal intubation, and to
minimize introduction of VAP bacteria into the lungs. For these
reasons, INNOVENT believes that its respiratory clearance system
will have a significant impact on decreasing the incidence of VAP
in the ICU.
INNOVENT's product pipeline includes a second generation device
that will be fully integrated into a specific brand of
ventilator. The result will be a unique ventilator: one that
clears secretions automatically and non-invasively as it
ventilates.
In addition to its ICU devices, Innovent is using its core
technology to develop a home-care clearance system for
non-ventilated patients. This device will clear the airways of
patients who are unable to cough effectively as a result of
neuromuscular diseases like muscular dystrophy, spinal cord
injury, multiple sclerosis and Lou Gehrig's Disease.
Most of the components used in the Innovent system are
"off-the-shelf." This accelerates our time-to-market and provides
attractive sales margins. Premarket clinical trials will be
carried out in Intensive Care Units in 2008, paving the way for
applications for CE and FDA regulatory approval via the 510K
route. The INNOVENT device has been endorsed by international
opinion leaders in the field of Intensive Care medicine, from
Mass. General Hospital in Boston and the University of Washington
Medical Center in Seattle. Market launch is projected for Q1
2009.
